INR 145.5
(1.35%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 113.4 Million INR | -87.2% |
2022 | 886.1 Million INR | 2.0% |
2021 | 868.7 Million INR | 60.04% |
2020 | 542.82 Million INR | 53.28% |
2019 | 354.13 Million INR | 0.24% |
2018 | 353.28 Million INR | 9.01% |
2017 | 324.06 Million INR | -35.97% |
2016 | 506.09 Million INR | -32.43% |
2015 | 748.98 Million INR | -11.17% |
2014 | 843.13 Million INR | -19.2% |
2013 | 1.04 Billion INR | 7.2% |
2012 | 973.38 Million INR | -62.38% |
2011 | 2.58 Billion INR | 315.56% |
2010 | 622.64 Million INR | -74.58% |
2009 | 2.44 Billion INR | 2.75% |
2008 | 2.38 Billion INR | 17.54% |
2007 | 2.02 Billion INR | 64.76% |
2006 | 1.23 Billion INR | -12.28% |
2005 | 1.4 Billion INR | 19.2% |
2004 | 1.17 Billion INR | 38.63% |
2003 | 849.25 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 113.4 Million INR | -87.2% |
2023 Q2 | 865.4 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 113.4 Million INR | 0.0% |
2022 Q2 | 875.9 Million INR | 0.0% |
2022 Q4 | 886.1 Million INR | 0.0% |
2022 FY | 886.1 Million INR | 2.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2021 Q3 | - INR | -100.0% |
2021 FY | 868.7 Million INR | 60.04% |
2021 Q2 | 695.3 Million INR | 0.0% |
2021 Q4 | 868.7 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2020 Q2 | 389 Million INR | 0.0% |
2020 Q4 | 542.82 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 542.82 Million INR | 53.28% |
2020 Q3 | - INR | -100.0% |
2019 Q2 | 293.9 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 354.13 Million INR | 0.0% |
2019 FY | 354.13 Million INR | 0.24% |
2018 FY | 353.28 Million INR | 9.01% |
2018 Q4 | 353.28 Million INR | 0.0% |
2017 FY | 324.06 Million INR | -35.97% |
2017 Q4 | 324.06 Million INR | 0.0% |
2016 Q4 | 506.1 Million INR | 0.0% |
2016 FY | 506.09 Million INR | -32.43% |
2015 Q3 | - INR | -100.0% |
2015 FY | 748.98 Million INR | -11.17% |
2015 Q4 | 748.98 Million INR | 0.0% |
2015 Q2 | 782 Million INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2014 Q3 | - INR | -100.0% |
2014 Q4 | 843.13 Million INR | 0.0% |
2014 FY | 843.13 Million INR | -19.2% |
2014 Q1 | - INR | -100.0% |
2014 Q2 | 952.4 Million INR | 0.0% |
2013 Q2 | 990.7 Million INR | 0.0% |
2013 Q4 | 1.04 Billion INR | 0.0% |
2013 FY | 1.04 Billion INR | 7.2% |
2013 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2012 FY | 973.38 Million INR | -62.38% |
2012 Q2 | 1.01 Billion INR | 0.0% |
2012 Q3 | - INR | -100.0% |
2012 Q4 | 973.38 Million INR | 0.0% |
2011 Q4 | 2.58 Billion INR | 0.0% |
2011 FY | 2.58 Billion INR | 315.56% |
2010 FY | 622.64 Million INR | -74.58% |
2009 FY | 2.44 Billion INR | 2.75% |
2008 Q4 | 2.38 Billion INR | 0.0% |
2008 FY | 2.38 Billion INR | 17.54% |
2007 FY | 2.02 Billion INR | 64.76% |
2006 FY | 1.23 Billion INR | -12.28% |
2005 FY | 1.4 Billion INR | 19.2% |
2004 FY | 1.17 Billion INR | 38.63% |
2003 FY | 849.25 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Sigachi Industries Limited | 707.2 Million INR | 83.965% |
Ind-Swift Limited | 640.91 Million INR | 82.307% |
Bajaj HealthCare Limited | 1.44 Billion INR | 92.127% |
Sakar Healthcare Limited | 277.32 Million INR | 59.109% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.884% |
Innova Captab Limited | 1.44 Billion INR | 92.126% |
Divi's Laboratories Limited | 31.84 Billion INR | 99.644% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 95.024% |
Morepen Laboratories Limited | 2.48 Billion INR | 95.438% |
Mankind Pharma Limited | 15.53 Billion INR | 99.27% |
Sequent Scientific Limited | 3.46 Billion INR | 96.725% |
Wanbury Limited | 360.23 Million INR | 68.52% |
Laurus Labs Limited | 18.45 Billion INR | 99.386% |
Nectar Lifesciences Limited | 7.09 Billion INR | 98.401% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 98.299% |
Hikal Limited | 3.03 Billion INR | 96.266% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.31% |
Neuland Laboratories Limited | 3.5 Billion INR | 96.764% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 97.743% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.549% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 97.331% |
Themis Medicare Limited | 705.74 Million INR | 83.932% |
RPG Life Sciences Limited | 1.01 Billion INR | 88.772% |
Zydus Lifesciences Limited | 34.41 Billion INR | 99.671% |
Lupin Limited | 49.53 Billion INR | 99.771% |
Amrutanjan Health Care Limited | 289.04 Million INR | 60.768% |
Wockhardt Limited | 6.4 Billion INR | 98.228% |
Vaishali Pharma Limited | 3.79 Million INR | -2886.568% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 98.236% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 24.385% |
Jubilant Pharmova Limited | 12.89 Billion INR | 99.121% |
FDC Limited | 3.88 Billion INR | 97.084% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.822% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -184.353% |
Eris Lifesciences Limited | 1.89 Billion INR | 94.001% |
Venus Remedies Limited | 1.21 Billion INR | 90.681% |
ZIM Laboratories Limited | 812.62 Million INR | 86.045% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 90.426% |
Par Drugs and Chemicals Limited | 41.77 Million INR | -171.487% |
Caplin Point Laboratories Limited | 3.63 Billion INR | 96.876% |
Shilpa Medicare Limited | 3.44 Billion INR | 96.712% |
Albert David Limited | 436.12 Million INR | 73.998% |
Ajanta Pharma Limited | 8.28 Billion INR | 98.631% |
Hester Biosciences Limited | 755.81 Million INR | 84.996% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 95.095% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 96.847% |
Gufic Biosciences Limited | 2 Billion INR | 94.344% |
Windlas Biotech Limited | 621.89 Million INR | 81.765% |
Procter & Gamble Health Limited | 1.09 Billion INR | 89.607% |
Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | 67.297% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 90.828% |
Granules India Limited | 13 Billion INR | 99.128% |
Aarti Drugs Limited | 4.85 Billion INR | 97.666% |
Bal Pharma Limited | 878.11 Million INR | 87.086% |
Alkem Laboratories Limited | 26.61 Billion INR | 99.574% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.885% |
Lincoln Pharmaceuticals Limited | 771.68 Million INR | 85.305% |
Medicamen Biotech Limited | 593.75 Million INR | 80.901% |
Unichem Laboratories Limited | 7.04 Billion INR | 98.391% |
Bafna Pharmaceuticals Limited | 296.41 Million INR | 61.743% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -344.758% |
Valiant Laboratories Limited | 100.15 Million INR | -13.226% |
Orchid Pharma Limited | 2.64 Billion INR | 95.708% |
Medico Remedies Limited | 163.37 Million INR | 30.588% |
Ind-Swift Laboratories Limited | 104.57 Million INR | -8.437% |
Ipca Laboratories Limited | 24.71 Billion INR | 99.541% |
Brooks Laboratories Limited | 96.1 Million INR | -17.992% |
Syncom Formulations (India) Limited | 210.81 Million INR | 46.209% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.502% |
NATCO Pharma Limited | 7 Billion INR | 98.381% |
Suven Life Sciences Limited | 7.08 Million INR | -1500.565% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | -15.757% |
Strides Pharma Science Limited | 11.26 Billion INR | 98.993% |
Indoco Remedies Limited | 3.53 Billion INR | 96.788% |
Alpa Laboratories Limited | 136.65 Million INR | 17.016% |
Lasa Supergenerics Limited | 190.43 Million INR | 40.452% |
Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -666.631% |